from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2450c/rpfE

LFCtreatmentdescriptionclass of inhibitor

1.397

Amikacinug/mL Amikacintranslation

1.174

Cap5-10ug/mL Capreomycintranslation

2.168

Rox10-50 ug/mL Roxithromycintranslation

0.522

SM2-5 ug/mL Streptomycintranslation

1.819

Tet5-10 ug/mL Tetracyclinetranslation

0.257

Rif0.2-5ug/mL Rifampicintranscription

-0.187

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.178

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.188

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.642

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.600

Clofazimine10-13 ug/mL Clofaziminerespiration

0.147

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.155

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.144

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.249

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.015

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.182

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.154

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.169

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.084

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.172

KCN5-20 ug/mL Potassium cyaniderespiration

0.613

NaN30.2-2 mM Sodium aziderespiration

1.624

Nigericin50 uM Nigericinrespiration

-1.065

TRC10-150 ug/mL Triclosanrespiration

-1.158

TRZ10-25 ug/mL Thioridazinerespiration

1.211

Valinomycin0.5-10 uM Valinomycinrespiration

-0.040

ZnSO42 mM ZnSO4respiration

-0.805

menadione6-10 ug/mL Menadionerespiration

0.706

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.698

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.499

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.729

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.023

NRP_1Non-replicating persistence stage 1dosRassociated

0.306

Amp0.2mg/mL AmpicillincellWall

0.309

Cephalexin20-100 ug/mL CephalexincellWall

0.738

Cerulenin0.32-5 ug/mL CerulenincellWall

0.689

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.475

EMB10-20 ug/mL EthambutolcellWall

-0.905

Eta12-40 ug/mL EthionamidecellWall

-0.341

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.224

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.311

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.354

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.937

BZA0.12 mg/mL BenzamidearomaticAmides

-0.749

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.382

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.217

H2O24 mM hydrogen peroxideDNAdamaging

-0.009

Levo10 ug/mL LevofloxacinDNAdamaging

0.680

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.014

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.925

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.198

UVUV-irradiationDNAdamaging

-1.112

ARP41-4 ug/mL Antitubercular compound ARP4?

0.680

Antimycin12.5-50 ug/mL Antimycin A?

-0.010

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.089

PA_110-50 ug/mL Antitubercular compound PA-1?

0.334

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.806

PA8240.2-2 ug/mL PA-824?

-0.614

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.283

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.152

Verapamil50 uM Verapamil?

1.002

mercaptoethanol2 mM 2-Mercaptoethanol?

0.742

methoxatin10-20 ug/mL Methoxatin?